Aridis Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-…

Biotechnology
US, Los Gatos [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Aridis Pharmaceuticals, Inc. has no acquisition track records yet.

M&A Deals · History

Aridis Pharmaceuticals, Inc. has no acquisition track records yet.

End of ARDS's Analysis
CIK: 1614067 CUSIP: 040334104 ISIN: US0403341045 LEI: - UEI: -
Secondary Listings
ARDS has no secondary listings inside our databases.